Heart-Vessel & Brain Link
Acute kidney injury significantly raises long-term risk of stroke, delirium, and dementia
A systematic review and meta-analysis pooling data from 49 studies and over 11 million participants found that acute kidney injury — a sudden episode of kidney dysfunction common during hospitalization — was associated with a 35% higher risk of stroke, 76% higher odds of delirium, and 64% higher risk of dementia in subsequent years. Risk increased with severity, with more advanced kidney injury stages roughly doubling stroke risk. Patients with kidney injury also faced markedly worse outcomes if they had a stroke: more than double the in-hospital mortality and nearly five times the 90-day mortality. The findings link kidney health to brain health in ways that extend well beyond chronic kidney disease, suggesting acute episodes may identify individuals at elevated risk for both immediate and long-term cognitive decline. Mechanisms likely include shared vascular injury, inflammation, and toxin accumulation that compromise brain integrity.
"Dirty-appearing" white matter doesn't predict dementia, but visible white matter damage does
A study of 2,081 older adults from the Reykjavik cohort distinguished between two MRI findings often grouped together: subtle "dirty-appearing" white matter changes and frank white matter hyperintensities — the brighter, more clearly visible damage seen on brain scans. Over 10 years of follow-up, dirty-appearing white matter showed no association with baseline cognition, cognitive decline, or dementia risk. In contrast, white matter hyperintensities at baseline tracked with worse executive function and processing speed, faster cognitive decline, and a 35% higher risk of dementia. The findings sharpen which MRI features carry prognostic weight for cognitive aging and reinforce that frank vascular injury to deep brain structures — not all subtle white matter changes — drives long-term cognitive risk. The distinction matters for interpreting clinical scans and counseling patients on what specific findings actually mean.
Brain's waste-clearance channels predict decade-long cognitive decline
Perivascular spaces — fluid-filled channels surrounding small blood vessels that help clear waste from the brain — emerge as a distinct marker of cerebral small vessel disease detectable on MRI. In a study of 750 adults followed for up to 11 years, higher burden of these visible spaces in the basal ganglia at baseline predicted worse longitudinal performance across multiple cognitive domains: naming, processing speed, executive function, visuospatial skills, and episodic memory. The association with executive function and visuospatial skills held even when other small vessel disease markers were accounted for, suggesting perivascular space dysfunction contributes independently to cognitive decline. The findings reinforce that vascular damage to deep brain structures — and impaired waste clearance through these channels — drives a measurable share of age-related cognitive loss.
Seizure medication choice affects survival in people with dementia and epilepsy
A Swedish national registry study of 5,764 adults with both dementia and epilepsy found that the choice of first seizure medication significantly affected survival over 17 years of follow-up. Compared to carbamazepine, valproate was associated with a 34% higher risk of death, while lamotrigine was associated with a 16% lower risk; levetiracetam showed a smaller protective trend. Cardiovascular causes of death were notably more common among valproate and carbamazepine users, suggesting older medications may worsen vascular risk in already-vulnerable patients. Epilepsy affects at least 5% of people with dementia, and the findings support guideline preference for newer medications — relevant for clinicians and families navigating treatment decisions in dementia care.
Autonomic dysfunction worsens cognitive fluctuations and behavior in Lewy body dementia
A multicenter study of 189 patients with moderate to advanced dementia with Lewy bodies followed for up to four years found that autonomic burden — symptoms like blood pressure dysregulation, GI problems, and temperature dysregulation — was directly tied to worse cognitive fluctuations, greater neuropsychiatric symptoms, and lower caregiver quality of life. Cardiovascular autonomic symptoms most strongly tracked with cognitive fluctuations, supporting a vascular mechanism: cerebral blood flow disruption may drive the abrupt minute-to-hour shifts in awareness that define Lewy body disease. Gastrointestinal and peripheral autonomic problems most strongly tied to neuropsychiatric symptoms. The findings point to autonomic function as an underexplored therapeutic target, where managing blood pressure variability, bowel function, and related symptoms could meaningfully improve quality of life for patients and caregivers.
Blood markers of brain cell injury predict both dementia and cardiovascular death
In a biracial cohort of 917 adults followed for over a decade, elevated plasma levels of two neurodegeneration markers — glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) — strongly predicted death from dementia, cardiovascular disease, and all causes combined. Each standard-deviation increase in GFAP raised dementia mortality risk more than fivefold and cardiovascular mortality risk roughly twofold; NfL showed similar dual associations. The findings reinforce that brain cell injury and vascular health are biologically intertwined: damage in one system signals risk in the other, and shared risk factors mean what protects the heart and vessels also tends to protect the brain.
Cardiac Function and Brain Health: A Meta-Analysis
This large-scale meta-analysis, involving over 15,000 participants from multiple community-based cohorts, establishes a robust link between cardiac performance and structural brain health. Researchers found that lower cardiac index (the amount of blood the heart pumps relative to body size) is significantly associated with smaller total brain volume and increased white matter hyperintensities. Furthermore, markers of cardiac stress, such as elevated NT-proBNP, were strongly linked to lower hippocampal volume and poorer global gray matter integrity. These findings suggest that subclinical "cardiac insufficiency" may lead to chronic cerebral hypoperfusion (reduced blood flow), depriving the brain of oxygen and nutrients long before the onset of clinical heart failure. This study reinforces the Heart-Vessel & Brain Link pillar, demonstrating that a strong pump is essential for maintaining a healthy brain.
Source: https://doi.org/10.1212/WNL.0000000000213421
White Matter Hyperintensities and Hippocampal Atrophy
This longitudinal study from Insight46 (the 1946 British Birth Cohort) examines the relationship between the progression of small vessel disease and neurodegeneration. Researchers found that a higher rate of increase in white matter hyperintensity volume (WMHV)—a marker of vascular-driven brain injury—is significantly associated with an accelerated rate of hippocampal atrophy. Crucially, this link persists even after accounting for amyloid-beta pathology and genetic risk factors, suggesting that vascular damage contributes to hippocampal shrinkage independently of Alzheimer's-specific proteins. The study also found that this relationship is partially mediated by neuroaxonal degradation (measured by plasma neurofilament light). These findings underscore the importance of managing vascular health to preserve the structural integrity of memory centers, placing this research firmly within the Heart-Vessel & Brain Link pillar.
Enlarged Perivascular Spaces and Early Biomarkers of Alzheimer’s
This study from the Biomarkers and Cognition Study, Singapore, investigates the relationship between enlarged perivascular spaces (EPVS) in the basal ganglia and early Alzheimer’s pathology. By analyzing a multiethnic Southeast Asian cohort, researchers found that higher EPVS burden is significantly associated with elevated levels of amyloid-β oligomers and p-tau181 in the blood. Notably, these vascular changes were linked to poorer performance in executive function and memory, particularly among those with mild cognitive impairment. The findings suggest that EPVS—which reflect impaired fluid clearance in the brain—serve as an early indicator of a synergistic "double hit" of vascular and protein pathology. Monitoring these spaces provides a vital diagnostic window within the Heart-Vessel & Brain Link to identify at-risk individuals before significant neurodegeneration occurs.
Platelet Aggregation and Midlife Markers of Alzheimer’s Disease
This cross-sectional study from the Framingham Heart Study investigates the link between midlife platelet function and early Alzheimer’s disease (AD) pathology. Researchers found that higher platelet aggregation—specifically in response to adenosine diphosphate (ADP)—is significantly associated with increased cortical tau deposition and reduced white matter integrity, even in cognitively asymptomatic middle-aged adults. Interestingly, this association was not observed with amyloid-beta, suggesting that platelet-mediated mechanisms may specifically drive tau-related neurodegeneration. These findings imply that systemic hemostatic activity and "sticky" platelets contribute to early vascular-driven brain injury. By identifying platelet reactivity as a potential modifiable risk factor, this research highlights a novel therapeutic target within the Heart-Vessel & Brain Link to intervene decades before dementia symptoms appear.
Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia
This study from the Framingham Heart Study evaluates whether a cumulative score of cerebral small vessel disease (CSVD) markers can predict dementia risk better than traditional vascular risk factors. Researchers analyzed MRI scans for four specific markers: cerebral microbleeds, covert brain infarcts, extensive white matter hyperintensities, and high perivascular space burden. The results demonstrated that individuals with a higher multimarker CSVD score had a significantly increased risk of incident dementia, independent of the Framingham Stroke Risk Profile. This suggests that the "silent" accumulation of vascular damage provides critical prognostic information beyond standard clinical measures like blood pressure or age. By quantifying the total burden of subclinical injury, this research emphasizes the need for aggressive monitoring within the Heart-Vessel & Brain Link to mitigate long-term cognitive decline.
Stroke, Cardiovascular Disease, and Dementia After Hospitalized TIA
Using data from the multi-decade Atherosclerosis Risk in Communities (ARIC) study, this research quantifies the long-term sequelae following a hospitalized transient ischemic attack (TIA). The study found that individuals who experienced a TIA had a significantly elevated risk of developing incident dementia, with a hazard ratio of 1.42 compared to those without TIA. Furthermore, the risk of a subsequent full-blown stroke was highest in the immediate period following the event, while the increased risk for dementia persisted over the long term. These findings underscore that a TIA is not merely a transient event but a critical warning sign of systemic vascular fragility and future cognitive decline. Managing post-TIA care is a vital intervention within the Heart-Vessel & Brain Link to prevent the progression from minor ischemia to major neurodegenerative impairment.
Cerebral Small Vessel Disease, Gray Matter Integrity, and Cognitive Function
This population-based study from the Hamburg City Health Study investigates how Cerebral Small Vessel Disease (CSVD) burden impacts cognitive function through the degradation of gray matter integrity. By utilizing a composite CSVD score—aggregating white matter hyperintensity load, Fazekas score, perivascular space count, and Peak Width of Skeletonized Mean Diffusivity (PSMD)—researchers demonstrated that vascular burden is strongly associated with reduced cortical thickness and subcortical volume. Specifically, the study highlights that CSVD-related changes in the hippocampus and temporal cortex serve as critical mediators for global cognitive impairment. These findings emphasize that vascular pathology does not just affect "wiring" but directly erodes the "processing units" of the brain. Monitoring and managing these vascular markers is a primary objective within the Heart-Vessel & Brain Link to prevent secondary neurodegeneration.
AD, Vascular Disease, and Blood-Brain Barrier Permeability in Midlife
This cross-sectional study investigates the relationship between blood-brain barrier (BBB) permeability, Alzheimer’s disease (AD) pathology, and small vessel disease in a diverse cohort of middle-aged adults. Utilizing plasma biomarkers, researchers found that increased BBB permeability—marked by elevated levels of PlGF, VEGF-D, and bFGF—is significantly associated with higher white matter hyperintensity (WMH) volume and elevated neurofilament light (NfL) levels. Notably, these markers of vascular dysfunction were more strongly linked to cerebrovascular injury than to amyloid or tau pathology in this age group. The findings suggest that BBB leakage and angiogenic signaling may be early, independent drivers of cognitive decline. By identifying these vascular-specific mechanisms, the study highlights critical intervention points within the Heart-Vessel & Brain Link to preserve neurological health before the onset of symptomatic dementia.